Wenjing Liu

ORCID: 0000-0003-0379-7038 · 7 papers in corpus
nonrandomized-trial 2026
Molecular therapy : the journal of the American Society of Gene Therapy ·doi:10.1016/j.ymthe.2025.09.035

Clinical application of mesenchymal stem cells for endometrial repair has been hampered by variability in cell quality, large-scale production, and uncertainty regarding the optimal delivery route. In this study, we investigated the therape…

meta-analysis 2025
Frontiers in oncology ·doi:10.3389/fonc.2025.1600459

OBJECTIVES: To determine the association between hysterectomy performed for benign indications and the risk of developing BC. METHODS: A literature search was conducted in PubMed, Embase, and the Cochrane Library from database inception up…

lab-animal 2025
Antioxidants (Basel, Switzerland) ·doi:10.3390/antiox14040444

Oxidative stress is a significant factor affecting reproductive efficiency in dairy cows, contributing to conditions such as endometritis that impair fertility and milk production. This study investigates the molecular mechanisms by which b…

lab-animal 2025
Antioxidants (Basel, Switzerland) ·doi:10.3390/antiox14030251

Potassium permanganate (KMnO4) is a commercially available antiseptic used in bovine intrauterine lavage to manage postpartum infections. Lipopolysaccharides (LPS) are well-studied for their ability to induce inflammation and oxidative stre…

2024
·doi:10.22541/au.172853847.75682264/v1

IntroductionEndometriosis was first described by Rokitansky in 1860. It refers to the appearance of endometrial tissue outside the uterine cavity. The incidence rate of endometriosis in women of childbearing age is about 10%–12%; in 5%–12% …

other 2024
Frontiers in endocrinology ·doi:10.3389/fendo.2024.1484007

INTRODUCTION: Ureaplasma urealyticum (UU) is a common pathogen associated with genital tract infections in infertile males. However, its impact on semen quality, embryo development, and in vitro fertilization (IVF) outcomes remains underexp…

nonrandomized-trial 2020
Cell proliferation ·doi:10.1111/cpr.12938

OBJECTIVE: Premature ovarian insufficiency (POI) is a refractory disease that seriously affects female fertility. Growing body of evidence has indicated mesenchymal stem cells (MSCs) as promising resources in regenerative medicine. In this …